Seminars in Cutaneous Medicine and Surgery 1997-03-01

Dyschromatosis.

K Urabe, Y Hori

Index: Semin. Cutan. Med. Surg. 16(1) , 81-5, (1997)

Full Text: HTML

Abstract

The dyschromatoses are a group of disorders characterized by the presence of both hyperpigmented and hypopigmented macules, many of which are small in size and irregular in shape. There are two major forms-dyschromatosis symmetrica hereditaria (DSH) and dyschromatosis universalis hereditaria (DUH), both of which are seen most commonly in Japan. DSH was first described by Toyama in 1929 and is characterized by a symmetrical distribution of hyperpigmented and hypopigmented macules on the extremities, especially over the dorsa of the hands and feet. In 1933, Ichikawa and Hiraga were the first to describe DUH as well-demarcated brown macules admixed with various-sized hypopigmented macules in a generalized as opposed to acral distribution. DUH was noted to appear within the first month of life. Some clinicians have suggested that DSH might be a subtype of DUH; however, we have to wait for the cloning of the causal genes of these diseases before coming to any definite conclusions. The differential diagnosis of dyschromatosis includes xeroderma pigmentosum, dyschromic amyloidosis, and exposure to chemicals such as diphenylcyclopropenone and monobenzyl ether of hydroquinone.


Related Compounds

Related Articles:

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.

2005-09-08

[J. Med. Chem. 48 , 5666-74, (2005)]

Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.

2014-12-01

[Arch. Biochem. Biophys. 563 , 71-8, (2014)]

Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

2012-11-01

[J. Invest. Dermatol. 132(11) , 2601-9, (2012)]

Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.

2010-01-01

[J. Invest. Dermatol. 130(1) , 211-20, (2010)]

More Articles...